Multiples are the “complication after success” in IVF — in the past, transferring 2–3 embryos made twins and triplets common, but with elective single embryo transfer (SET) the multiple rate is now falling fast. This article clarifies how large the risk is, when doctors advise reduction, how the procedure works, and what you should really do: prevent it upfront.
This article draws on the American Society for Reproductive Medicine (ASRM) committee opinion on embryo transfer number and multifetal reduction, the ESHRE guideline on elective single embryo transfer, and the U.S. CDC ART surveillance system. It was compiled by the ProIVF Medical Editorial Team and reviewed by the ProIVF Medical Advisory Board.
Why are IVF pregnancies more likely to be multiples?
Natural twinning occurs in about 1%–2% of pregnancies, while the IVF multiple rate is almost entirely determined by how many embryos were transferred. One embryo (SET) → multiple rate near natural; two → twin rate rises sharply, triplets possible; three or more → triplet and higher-order risk climbs steeply.
This is why ASRM and ESHRE consistently recommend SET for good-prognosis patients (especially under 35 with good blastocysts). For embryo culture and grading, see our ICSI guide.
What risks do multiples pose to mother and baby?
Multiples are not simply “two for the price of one” — the uterus is designed for one. Maternal and fetal risks stack with each additional fetus, and the core threat is preterm birth.
For the mother: risk of gestational hypertension and preeclampsia about 2–3 times that of a singleton; higher rates of gestational diabetes and anemia; significantly higher postpartum hemorrhage and Cesarean rates.
For the baby: preterm birth (over half of twins born before 37 weeks, nearly all triplets), low birth weight, neonatal respiratory distress, and neurodevelopmental risks that rise with fetal number.
| Metric | Singleton | Twins | Triplets+ |
|---|---|---|---|
| Mean delivery week | ~39 wk | ~36 wk | <34 wk common |
| Preterm (<37 wk) rate | ~10% | ~50%–60% | near 100% |
| Low birth weight risk | baseline | clearly higher | markedly higher |
| Perinatal mortality | baseline | higher | markedly higher |
In one sentence: the main threat of multiples is preterm birth, which then pulls in a chain of NICU stays, developmental delay, and long-term care burdens.
When do doctors say “we advise reduction”?
Reduction (multifetal pregnancy reduction / selective reduction) is a very difficult decision, but medically there are clear indications. Triplets and above almost always prompt a reduction recommendation — the risks of extreme prematurity and perinatal death are too high, and maternal burden is enormous.
- Triplets and above: almost always reduced to twins or a singleton.
- Twins with high-risk factors: e.g., monochorionic twins with twin–twin transfusion syndrome (TTTS) risk, maternal preeclampsia/hypertension history, uterine anomaly, or one fetus with a lethal anomaly.
- Fetal anomaly: if screening finds a severe chromosomal or structural anomaly in one fetus, that fetus can be selectively reduced to save the healthy one.
There are two approaches: multifetal reduction (triplets down to twins or singleton) and selective reduction (only the abnormal one).
How is fetal reduction performed?
Reduction is done under ultrasound guidance, most often at 11–14 weeks (after the NT scan); early transvaginal at 8–10 weeks, mid-trimester transabdominal. The exact timing depends on fetal number, chorionicity, and center experience.
- Method: under ultrasound, a fine needle is passed to the target fetus’s heart or chest and potassium chloride is injected to stop the heartbeat; monochorionic twins may use “umbilical cord occlusion” to spare the other fetus.
- Anesthesia and process: mostly local, outpatient or short stay, full ultrasound monitoring, usually tens of minutes.
- Risks: in experienced centers, the miscarriage risk from reduction is mostly under 5%, but bleeding and infection remain possible; close monitoring follows.
“For good-prognosis patients, elective single embryo transfer (eSET) should be recommended to minimize the risk of iatrogenic multiples.” — ESHRE Guideline Group on Good Practice in IVF
Beyond reduction: the psychology and ethics
Reduction is among the heaviest decisions in reproductive medicine, and reputable centers provide genetic counseling and psychological support that emphasize informed consent. There is no “standard answer” — only a trade-off between minimizing risk and family capacity, so give yourself and your partner room to decide and don’t carry it alone.
If you are weighing transfer number against risk, our pros and cons of IVF article offers a fuller decision view.
Does single embryo transfer (SET) really prevent multiples?
Better than “reduce after conceiving” is “don’t conceive multiples in the first place.” SET does not lower cumulative live birth — extra embryos are frozen, and if the first fails, a later transfer keeps cumulative live birth on par with double transfer while driving the multiple rate to the floor.
| Strategy | Multiple rate | Cumulative live birth | Best for |
|---|---|---|---|
| SET | lowest (near singleton) | on par with DET (frozen adds up) | <35, good blastocyst |
| DET | clearly higher | slightly higher per cycle | poor prognosis, repeated failure, older |
| 3+ embryos | high (triplets common) | not recommended | largely phased out by guidelines |
Guideline position: ASRM and ESHRE both recommend SET for young, good-prognosis patients as the core strategy to lower iatrogenic multiples. For cost and cycle planning, see the IVF cost guide and the IVF preparation checklist.
Real patient stories
The following patient stories are shared with consent. To protect privacy, names and identifying details have been altered.
Case 1: Twins reduced to a singleton — Lin, 38, Shanghai. Lin’s two transferred embryos both implanted as twins, but she has chronic hypertension. The doctor judged twin preeclampsia risk too high and advised reducing one. The reduction cost about ¥12,000 self-pay; the remaining singleton progressed to term and delivered by Cesarean. “The decision was hard, but the doctor explained the risks very clearly,” she said.
Case 2: Triplets reduced to twins — Xiao Yu, 29, Hangzhou. All three transferred embryos implanted. Obstetric and reproductive specialists advised reducing to twins to lower extreme-prematurity risk. The reduction cost about ¥10,000 self-pay; the twins stayed stable, delivering at 34+ weeks — both healthy. “If we’d transferred only one, maybe we’d have skipped all this,” Xiao Yu reflected.
Case 3: Insisted on SET, singleton live birth — Anna, 32, Shenzhen. Anna requested SET at her first consult. The doctor agreed given her good blastocyst, and one transfer led to a singleton, full-term vaginal delivery, about ¥35,000 for the single cycle. “Less suffering, better for the baby,” she summarized.
FAQ
Q1: How many embryos should I transfer?
It depends on prognosis: major guidelines cap recommended transfers at 1–2, and young patients (under 35) with good blastocysts should prefer SET while poor prognosis, repeated failure, or older age may justify two. Three or more embryos is essentially no longer recommended.
Q2: Is fetal reduction safe, and will it harm the remaining baby?
In experienced centers, the miscarriage risk from reduction is mostly under 5%, but bleeding and infection remain possible. Under ultrasound, the target fetus is addressed while protecting the remaining one; monochorionic twins use cord-occlusion techniques to spare the other.
Q3: Must triplets always be reduced?
From a maternal-fetal safety view, triplets almost always prompt reduction — mean delivery <34 weeks and near-100% preterm rate make the risks too high, and maternal burden enormous. The final decision is shared with your doctor, but the medical indication is very clear.
Q4: Can I still get pregnant and deliver after reduction?
In experienced centers the miscarriage risk from reduction is mostly <5%, and the retained fetus very often continues to term. Reduction itself does not necessarily affect future fertility, but any uterine procedure carries a small complication risk requiring follow-up.
Q5: Does SET lower my success rate?
Per-cycle live birth may be slightly lower than transferring two, but SET drops the multiple rate from about 30%–40% with double transfer to near-singleton 1%–2%, while cumulative live birth (adding frozen transfers) matches double transfer. For good-prognosis patients, SET is the “smarter” choice.
Q6: Must multiple pregnancy always be reduced?
Not necessarily — twins make up the vast majority of IVF multiples (about 50%–60% born before 37 weeks), but not all require reduction, and twins with stable maternal-fetal status and no high-risk factors can often continue under close monitoring. Reduction is actively advised only with high-risk factors (e.g., TTTS, severe maternal complications, lethal fetal anomaly) or triplets and above.
How to plan your transfer strategy
Multiples are a byproduct of IVF success, but should not be romanticized. The key is not “reduce after conceiving” but discussing transfer number with your doctor before transfer:
- Assess prognosis: age, embryo quality (blastocyst? grade?), PGT, prior failures decide transfer number.
- SET when possible: young patients with good blastocysts should prefer SET, minimizing multiples.
- Don’t panic if already multiples: evaluate risk with reproductive and obstetric teams; reduce at the right gestational week in an experienced center if needed.
- Decide informed: whichever path, being informed, calm, and supported is the best choice.
If you are already carrying multiples, don’t panic — evaluate with your doctor and bring the risk to a manageable level. This article also references the ESHRE SET guideline and ASRM patient education.
This article was written by the ProIVF Medical Editorial Team and reviewed by the ProIVF Medical Advisory Board. The creation process is based on the ASRM committee opinion on embryo transfer number and multifetal reduction, the ESHRE SET guideline, and the U.S. CDC ART surveillance system, aiming to provide objective, accurate health information.
Disclaimer: This article is for general education only and is not medical advice. Multiples management and reduction indications/timing are highly individualized — rely on your reproductive and obstetric doctors’ combined assessment.
Last updated: October 17, 2026
